Bo E. Hedlund - Concepedia

Author

Bo E. Hedlund

Also Known As

B E Hedlund, B Hedlund, B. E. Hedlund, B. Hedlund, B.E Hedlund, B.E. Hedlund, BO E. HEDLUND, Bo E Hedlund, Bo E. Hedlund, Bo Hedlund

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Minnesota Biomedical Frontiers (United States)University of Minnesota Medical Center Stanford University University of Iowa

About

Bo E. Hedlund is an author at University of Minnesota specializing in medicine, biochemistry, and redox biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.2K
2	Natural Sciences	4	4	369
3	Engineering	2	2	220
4	Health Sciences	2	2	52
5	Public Health	1	1	156

Bo E. Hedlund

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Robert P. Hebbel, William T. Morgan, John W. Eaton, Proceedings of the National Academy of Sciences Heme LossBiochemistrySickle HemoglobinHeme TransferMutant Gene Product	1988	304
Role of iron in postischemic renal injury in the rat Mark S. Paller, Bo E. Hedlund, Joseph J. Sikora, Kidney International UrologyRenal FunctionIron MetabolismPhysiologyPostischemic Renal Injury	1988	220
Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Philip E. Hallaway, John W. Eaton, S. Scott Panter, Proceedings of the National Academy of Sciences EngineeringLipid PeroxidationRedox BiologyOxidative StressPolymers	1989	187
Abnormal iron distribution in infants of diabetic mothers: Spectrum and maternal antecedents Michael Georgieff, Mark B. Landon, Marla M. Mills, The Journal of Pediatrics NutritionIron MetabolismFetal HealthMaternal NutritionPublic Health	1990	156
Acute iron poisoning. Rescue with macromolecular chelators. John R. Mahoney, Philip E. Hallaway, Bo E. Hedlund, Journal of Clinical Investigation Reactive IronIron MetabolismPharmacotherapyExperimental PharmacologyOxidative Stress	1989	63
First human studies with a high-molecular-weight iron chelator Paul R. Dragsten, Philip E. Hallaway, Gregory J. Hanson, Journal of Laboratory and Clinical Medicine Iron MetabolismMossbauer SpectroscopyAnalytical ChemistryChemistryFirst Human Studies	2000	57
Sickle hemoglobin oxygen affinity‐shifting strategies have unequal cerebrovascular risks Robert P. Hebbel, Bo E. Hedlund American Journal of Hematology	2017	50
Extracellular iron chelators protect kidney cells from hypoxia/reoxygenation Mark S. Paller, Bo E. Hedlund Free Radical Biology and Medicine BiochemistryExtracellular Iron ChelatorsHypoxia (Medicine)Reactive Oxygen SpecieMetabolism	1994	49
Iron deprivation increases erythropoietin production <i>in vitro</i>, in normal subjects and patients with malignancy Pamela J. Kling, Paul R. Dragsten, Robin Roberts, British Journal of Haematology	1996	42
Phase Ib clinical trial of starch‐conjugated deferoxamine (40SD02): a novel long‐acting iron chelator Paul Harmatz, Robert W. Grady, Paul R. Dragsten, British Journal of Haematology	2007	42

Page 1